Skip to content

Advertisement

  • Poster presentation
  • Open Access

The association between microvascular obstruction by CMR and the index of microcirculatory resistance assessed invasively

  • 1,
  • 2,
  • 2,
  • 2,
  • 3,
  • 3,
  • 2 and
  • 1
Journal of Cardiovascular Magnetic Resonance201416 (Suppl 1) :P212

https://doi.org/10.1186/1532-429X-16-S1-P212

  • Published:

Keywords

  • Acute Myocardial Infarction
  • Infarct Size
  • Stent Insertion
  • Regional Ethic Committee
  • Microvascular Obstruction

Background

Microvascular obstruction (MVO) by CMR is a predictor of poor prognosis following acute myocardial infarction. The index of microcirculatory resistance (IMR) is an invasive measurement of the microcirculation that has recently been shown to predict poor long-term outcomes [1]. The aim of the study was to determine the association between MVO by CMR and the IMR measured at the time of primary percutaneous intervention (PPCI) in patients with ST-elevation myocardial infarction (STEMI).

Methods

48 patients were prospectively recruited to the study. Inclusion criteria were: presentation with STEMI within 12 hours of symptoms and TIMI flow I or 0 in the infarct related artery. Patients needed to proceed with PPCI in a large epicardial artery. Patients with contraindications for CMR were excluded from the study. IMR was performed using a pressure thermistor wire (Certus, St Jude) at maximal hyperaemia using adenosine, and following stent insertion. CMR was performed at day 2 following STEMI. We used an IMR cut off of 40 that has been shown to predict prognosis(1), and IMR quartiles to investigate an association between MVO and IMR. The difference between IMR quartiles was assessed using the Kruskal-Wallis test. The difference between MVO in patents with an IMR more or less than 40 was assessed using the Mann-Witney test. All patients provided informed written consent and the study was approved by the regional ethics committee.

Results

The median IMR was 38.5 (range 9 to 202). The median MVO was 1.9% LV (range 0 to 21.0% LV). There was a significant increase in MVO as IMR increased (p = 0.007) (Figure 1a). This is more pronounced when MVO was indexed to infarct size (MVO/Infarct size, MVOI) (p = 0.003) (Figure 1b). The IMR cut-off of 40 significantly predicted the presence of MVO on CMR (p = 0.0003) (Figure 2).
Figure 1
Figure 1

a) MVO vs. IMR (p = 0.007) Figure 1b) MVOI vs. IMR (p = 0.003).

Figure 2
Figure 2

MVO predicted by IMR > and < 40 (p = 0.0003).

Conclusions

IMR is significantly associated with MVO on CMR day 2 following STEMI. This study provides an invasive functional insight into MVO measured non-invasively by CMR.

Funding

This study was funded by the David Telling Charitable Trust and the NIHR Bristol Cardiovascular Biomedical Research Unit.

Authors’ Affiliations

(1)
CMR Unit, NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, Bristol, UK
(2)
Cardiology, Bristol Heart Institute, Bristol, UK
(3)
Clinical Trials and Evaluation Unit, University of Bristol, Bristol, UK

References

  1. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG: Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013, 127 (24): 2436-41. 10.1161/CIRCULATIONAHA.112.000298.View ArticlePubMedGoogle Scholar

Copyright

© McAlindon et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement